Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
National Bank of Canada
TSX:NA
|
CA |
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
US |
|
N
|
Niterra Co Ltd
XMUN:NGK
|
JP |
|
Caterpillar Inc
NYSE:CAT
|
US |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
Currys PLC
LSE:CURY
|
UK |
|
Creek & River Co Ltd
TSE:4763
|
JP |
|
Teck Resources Ltd
NYSE:TECK
|
CA |
|
D
|
Dalrymple Bay Infrastructure Ltd
ASX:DBI
|
AU |
|
G
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
US |
|
Penske Automotive Group Inc
NYSE:PAG
|
US |
|
CONSOL Energy Inc
NYSE:CEIX
|
US |
|
B.P. Marsh & Partners PLC
LSE:BPM
|
UK |
|
Daehan Shipbuilding Co Ltd
KRX:439260
|
KR |
|
Cushman & Wakefield PLC
NYSE:CWK
|
UK |
|
T
|
Thai Vegetable Oil PCL
SET:TVO
|
TH |
Wall St Price Targets
IOVA Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.61 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
8.61
USD
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.61 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
18%
The compound annual growth rate for Revenue over the next 8 years is 18%.